MIRA: MIRA Pharmaceuticals, Inc. Stock

by  •  • Comments Off on MIRA: MIRA Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 20.26
Enterprise Value ($M) 17.43
Book Value ($M) 2.20
Book Value / Share 0.13
Price / Book 9.21
NCAV ($M) 2.16
NCAV / Share 0.13
Price / NCAV 9.36

Profitability (mra)
Return on Invested Capital (ROIC) -3.57
Return on Assets (ROA) -2.06
Return on Equity (ROE) -2.49

Liquidity (mrq)
Quick Ratio 3.99
Current Ratio 3.99

Balance Sheet (mrq) ($M)
Current Assets 2.89
Assets 2.92
Liabilities 0.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.02
Net Income -7.85

Cash Flow Statement (mra) ($M)
Cash From Operations -5.56
Cash from Investing 0.00
Cash from Financing 3.79

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 2
2025-04-15 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No.1
2025-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 35,236 173,401 20.32
2025-05-08 454,175 1,463,930 31.02
2025-05-07 44,489 164,682 27.02
2025-05-06 126,977 382,155 33.23
2025-05-05 18,539 78,409 23.64

(click for more detail)

Similar Companies
MBIO – Mustang Bio, Inc. MBRX – Moleculin Biotech, Inc.
MEIP – MEI Pharma, Inc. MLTX – MoonLake Immunotherapeutics
MNPR – Monopar Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io